Prostate Cancer Clinical Trial

Adherence Dynamics for Whole Food Interventions in African-American Men

Summary

The purposes of this study are to explore the dynamics of adherence, using a simple whole food intervention strategy, both prior to and during the intervention period and to identify nutrient shifts in self-selected diets and to determine health risks (blood pressure, hyperlipidemia, and body weight) that may have resulted from increased tomato product consumption.

View Full Description

Full Description

African-American (AA) men suffer the greatest proportion of health disparities of any studied category and adherence to advice among this group has been vastly understudied.

Although there are several ongoing trials for behavioral change, either of diet or lifestyle, enrollment rates of AA men (< 25%) often provide insufficient numbers to evaluate adherence issues separately.

Tomatoes, more than lycopene alone, may have beneficial effects on prostate health, including BPH and prostate cancer. Efficacy trials would require long-term adherence to high levels of tomato product (TP) consumption.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

African-American men aged ≥ 50 yr who recently were found to have serum prostate specific antigen (PSA) concentrations of >2.5 ng/mL with negative prostate biopsy for prostate cancer.
English literacy
willing to consume tomato products on a regular basis.

Exclusion Criteria:

prostate cancer diagnosis
other cancers < 5 yrs postdiagnosis except for melanoma
already consuming four 1/2 cup servings of tomato products/wk.

Study is for people with:

Prostate Cancer

Estimated Enrollment:

37

Study ID:

NCT01408459

Recruitment Status:

Completed

Sponsor:

University of Illinois at Chicago

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Illinois at Chicago
Chicago Illinois, 60606, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

37

Study ID:

NCT01408459

Recruitment Status:

Completed

Sponsor:


University of Illinois at Chicago

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider